This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Cepheid officials said last week that the firm has devised a five-year plan for assay development that will take it beyond its current focus on hospital-acquired infections and into other infectious diseases and oncology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.